학술논문
Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b–2a trial
Document Type
Article
Author
Madhi, S.A.; Kwatra, G.; Koen, A.L.; Baillie, V.; Briner, C.; Bhikha, S.; Mukendi, C.K.; Taoushanis, C.; Izu, A.; Cutland, C.L.; Richardson, S.I.; Kaldine, H.; Madzorera, V.S.; Manamela, N.P.; Hermanus, S.T.; Motlou, T.; Mzindle, N.; Moore, P.L.; Fairlie, L.; Horne, E.; Patel, F.; Rossouw, L.; van Eck, S.; Padayachee, S.D.; Ahmed, K.; Masilela, M.; Dheda, K.; Esmail, A.; Oelofse, S.; Barnabas, S.L.; Bhorat, Q.E.; Bhorat, A.E.; Lambe, T.; Gilbert, S.C.; Pollard, A.J.; Aley, P.K.; Rhead, S.
Source
In: The Lancet Infectious Diseases . (The Lancet Infectious Diseases, March 2023, 23(3):295-306)
Subject
Language
English
ISSN
14744457
14733099
14733099